Cannabis News

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company based in the United States announced today the opening of a new Florida dispensary, the Company's 91st nationwide.

The latest dispensary, located in Winter Park , supports Trulieve's goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. The dispensary expands access throughout Central Florida , joining four locations throughout nearby Orlando .

In honor of Trulieve's 85th Florida dispensary, all patients — from those new to Trulieve to the dedicated Truliever community — will be eligible for a 25% in-store discount at the new dispensary on opening day.

ANNOUNCING : Trulieve Winter Park Grand Opening
WHERE : 6840 Aloma Ave., Winter Park, FL 32792
WHEN : Thursday, June 24, 2021 , at 9:00 a.m.

In stores and online, patients will find Florida's largest selection of THC and CBD products in a variety of delivery methods, including edibles, smokable flower, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients and convenient in-store pickup at each of its 85 dispensaries in Florida .

To assist patients with ordering, Trulieve's entire catalog of products is available for online orders, with in-store pickup or statewide home delivery options available depending on patient preference. Additionally, Trulieve offers complimentary 30-minute virtual consultations with a Trulieve consultant to help navigate questions on products, devices, or review their doctor's recommendation. Appointments can be made on Trulieve's website and are open to all patients, whether starting their journey with medical cannabis or those with experience looking for alternative treatment options.

Trulieve continues to monitor the COVID-19  situation and to ensure the highest level of safety of our patients and staff. Per current CDC guidelines, we continue to encourage social distancing and the use of plexiglass shields. We encourage unvaccinated patients to also adhere to CDC guidelines and wear a mask in our stores.

For more information, please visit www.Trulieve.com .

About Trulieve
Trulieve is primarily a vertically integrated "seed-to-sale" company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida , as well as directly to patients via home delivery. Trulieve also holds licenses to operate in California , Massachusetts , Pennsylvania , Connecticut , and West Virginia . Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF .

To learn more about Trulieve, visit www.Trulieve.com .

Cision View original content: http://www.prnewswire.com/news-releases/trulieve-expands-access-to-medical-cannabis-in-central-florida-with-new-winter-park-location-301318760.html

SOURCE Trulieve Cannabis Corp.

Cision View original content: http://www.newswire.ca/en/releases/archive/June2021/23/c3820.html

News Provided by Canada Newswire via QuoteMedia

How Can MSOs be Ready for US Cannabis Reform?

How Can MSOs be Ready for US Cannabis Reform?

Although the US still lacks a regulated federal cannabis program, companies have been able to steadily grow, and a variety of financial experts have said the smart money is honing in on the country.

With reform now appearing imminent, companies focused on the American landscape are preparing for a new regime at the same time as they aim to move forward at the state level.

One multi-state operator (MSO) shared the adjustments it is making ahead of possible federal changes.

Keep reading...Show less
Adastra Expands Market Footprint Through Receipt of Medical Sales License from Health Canada

Adastra Expands Market Footprint Through Receipt of Medical Sales License from Health Canada

Adastra Holdings Ltd. (CSE:XTRX)(FRA:D2EP) ("Adastra" or the "Company"), a leading cannabis company focused on processing, product development, sales, organoleptic testing and analytical testing, is pleased to announce it has received its Medical Sales License from Health Canada which now authorizes Adastra to sell cannabinoid-containing products that are formulated for and distributed to the medical cannabis market

With its Medical Sales License, Adastra is now authorized to:

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Cresco Labs Announces Second Quarter 2022 Results

Company reports 4% year-over-year revenue growth and 11% year-over-year adjusted EBITDA growth; continues industry leadership with branded product performance and retail productivity

Company provides positive update on Columbia Care divestiture process, regulatory approvals and closing timeline

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Trulieve Opening Medical Marijuana Dispensary in Auburndale

New dispensary expands patient access to medical cannabis; grand opening specials available

9 p.m. from Monday through Saturday and 10 a.m8 p.m. on Sunday .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
Hygrovest

HGV Investment Portfolio Report July 2022

HGV Limited (ASX: HGV) ("HGV”)is an Australian-listed specialist investment company which concentrates on producing capital growth for shareholders over the medium term from investments in listed and unlisted equities and other financial assets.

Keep reading...Show less
VIDEO — HEXO CEO: Aggressive Pursuit of Clean Balance Sheet Has Reset Company

VIDEO — HEXO CEO: Aggressive Pursuit of Clean Balance Sheet Has Reset Company

It’s been a seriously difficult period for Canadian cannabis operators over the past few years, with volatility prevailing as the status quo for companies in the market.

Charlie Bowman, president and CEO of HEXO (NASDAQ:HEXO,TSX:HEXO), understands that, and that’s why his first order of business after taking the helm at the company was to clean up its finances. He sees a better path ahead for HEXO now that it has restructured its assets and had its debt purchased by a fellow Canadian producer.

Bowman spoke at length with the Investing News Network (INN) about the downturn in Canadian cannabis stocks, HEXO’s NASDAQ listing status and its partnership with Tilray Brands (NASDAQ:TLRY,TSX:TLRY).

Keep reading...Show less

Latest Press Releases

Related News

×